Myers Michael
- SEC CIK
- 0001959547
Latest role at each company
- QNRX Quoin Pharmaceuticals Ltd.Chief Executive Officeras of Sep 1, 2026
Trades
Every Form 4 that lists Myers Michael as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| QNRXQuoin Pharmaceuticals Ltd. | Sep 1, 20269:39 PM ET | Aug 31, 2026 | Myers MichaelChief Executive Officer | PPurchaseADSs | +20.49K | $4.88 | +$99.99K | 37.71K | +119.0% | SEC |
| QNRXQuoin Pharmaceuticals Ltd. | Sep 1, 20269:39 PM ET | Aug 31, 2026 | Myers MichaelChief Executive Officer | PPurchaseADS · Derivative | +10.25K | – | – | 10.25K | – | SEC |
| QNRXQuoin Pharmaceuticals Ltd. | Dec 27, 20245:16 PM ET | Dec 23, 2024 | Myers MichaelChief Executive Officer | PPurchaseOrdinary Shares | +555.56K | $0.45 | +$250K | 602.81K | +1,175.7% | SEC |
| QNRXQuoin Pharmaceuticals Ltd. | Dec 27, 20245:16 PM ET | Dec 23, 2024 | Myers MichaelChief Executive Officer | PPurchaseADS · Derivative | +1.11M | – | – | 555.56K | – | SEC |
| QNRXQuoin Pharmaceuticals Ltd. | Sep 5, 2024 | Sep 3 – Sep 4, 2024 | Myers MichaelChief Executive Officer | PPurchaseOrdinary Shares | +37.89K | $0.7657 | +$29.02K | 47.25K | +404.9% | SEC |